PortalPublikationenOutcomes of Primary Transconjunctival 23-Gauge Vitrectomy in...

Outcomes of Primary Transconjunctival 23-Gauge Vitrectomy in the Diagnosis and Treatment of Presumed Endogenous Fungal Endophthalmitis

Standard

Outcomes of Primary Transconjunctival 23-Gauge Vitrectomy in the Diagnosis and Treatment of Presumed Endogenous Fungal Endophthalmitis. / William, Antony; Spitzer, Martin S; Deuter, Christoph; Blumenstock, Gunnar; Partsch, Michael; Voykov, Bogomil; Ziemssen, Focke; Bartz-Schmidt, Karl Ulrich; Doycheva, Deshka.

in: OCUL IMMUNOL INFLAMM, Jahrgang 25, Nr. 2, 04.2017, S. 239-245.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

William, A, Spitzer, MS, Deuter, C, Blumenstock, G, Partsch, M, Voykov, B, Ziemssen, F, Bartz-Schmidt, KU & Doycheva, D 2017, 'Outcomes of Primary Transconjunctival 23-Gauge Vitrectomy in the Diagnosis and Treatment of Presumed Endogenous Fungal Endophthalmitis', OCUL IMMUNOL INFLAMM, Jg. 25, Nr. 2, S. 239-245. https://doi.org/10.3109/09273948.2015.1115080

APA

William, A., Spitzer, M. S., Deuter, C., Blumenstock, G., Partsch, M., Voykov, B., Ziemssen, F., Bartz-Schmidt, K. U., & Doycheva, D. (2017). Outcomes of Primary Transconjunctival 23-Gauge Vitrectomy in the Diagnosis and Treatment of Presumed Endogenous Fungal Endophthalmitis. OCUL IMMUNOL INFLAMM, 25(2), 239-245. https://doi.org/10.3109/09273948.2015.1115080

Vancouver

William A, Spitzer MS, Deuter C, Blumenstock G, Partsch M, Voykov B et al. Outcomes of Primary Transconjunctival 23-Gauge Vitrectomy in the Diagnosis and Treatment of Presumed Endogenous Fungal Endophthalmitis. OCUL IMMUNOL INFLAMM. 2017 Apr;25(2):239-245. https://doi.org/10.3109/09273948.2015.1115080

Bibtex

@article{e607475f9fb1431eb3468a684928fb7d,
title = "Outcomes of Primary Transconjunctival 23-Gauge Vitrectomy in the Diagnosis and Treatment of Presumed Endogenous Fungal Endophthalmitis",
abstract = "PURPOSE: To report the outcomes of primary transconjunctival 23-gauge (23-G) vitrectomy in the diagnosis and treatment of presumed endogenous fungal endophthalmitis (EFE).METHODS: Retrospective analysis of patients with EFE who underwent diagnostic transconjunctival 23-G vitrectomy at a tertiary referral center.RESULTS: Nineteen eyes of 15 patients with EFE were included in the study. Four patients had bilateral and 11 patients unilateral disease. Sixteen eyes of 15 patients underwent 23-G vitrectomy to confirm the diagnosis using vitreous culture, polymerase chain reaction, and histopathologic examinations. All affected eyes were treated with intravitreal amphotericin B 5 µg/0.1 mL. Fourteen patients received additional systemic antifungal therapy. Diagnostic 23-G vitrectomy confirmed the diagnosis of EFE in 75% of the eyes (12/16). Candida was found to be a causative agent in 62.5% and Aspergillus in 12.5% of the eyes. Retinal detachment was the most common complication (42% of eyes).CONCLUSIONS: EFE can be easily confirmed using primary 23-G vitrectomy.",
author = "Antony William and Spitzer, {Martin S} and Christoph Deuter and Gunnar Blumenstock and Michael Partsch and Bogomil Voykov and Focke Ziemssen and Bartz-Schmidt, {Karl Ulrich} and Deshka Doycheva",
year = "2017",
month = apr,
doi = "10.3109/09273948.2015.1115080",
language = "English",
volume = "25",
pages = "239--245",
journal = "OCUL IMMUNOL INFLAMM",
issn = "0927-3948",
publisher = "informa healthcare",
number = "2",

}

RIS

TY - JOUR

T1 - Outcomes of Primary Transconjunctival 23-Gauge Vitrectomy in the Diagnosis and Treatment of Presumed Endogenous Fungal Endophthalmitis

AU - William, Antony

AU - Spitzer, Martin S

AU - Deuter, Christoph

AU - Blumenstock, Gunnar

AU - Partsch, Michael

AU - Voykov, Bogomil

AU - Ziemssen, Focke

AU - Bartz-Schmidt, Karl Ulrich

AU - Doycheva, Deshka

PY - 2017/4

Y1 - 2017/4

N2 - PURPOSE: To report the outcomes of primary transconjunctival 23-gauge (23-G) vitrectomy in the diagnosis and treatment of presumed endogenous fungal endophthalmitis (EFE).METHODS: Retrospective analysis of patients with EFE who underwent diagnostic transconjunctival 23-G vitrectomy at a tertiary referral center.RESULTS: Nineteen eyes of 15 patients with EFE were included in the study. Four patients had bilateral and 11 patients unilateral disease. Sixteen eyes of 15 patients underwent 23-G vitrectomy to confirm the diagnosis using vitreous culture, polymerase chain reaction, and histopathologic examinations. All affected eyes were treated with intravitreal amphotericin B 5 µg/0.1 mL. Fourteen patients received additional systemic antifungal therapy. Diagnostic 23-G vitrectomy confirmed the diagnosis of EFE in 75% of the eyes (12/16). Candida was found to be a causative agent in 62.5% and Aspergillus in 12.5% of the eyes. Retinal detachment was the most common complication (42% of eyes).CONCLUSIONS: EFE can be easily confirmed using primary 23-G vitrectomy.

AB - PURPOSE: To report the outcomes of primary transconjunctival 23-gauge (23-G) vitrectomy in the diagnosis and treatment of presumed endogenous fungal endophthalmitis (EFE).METHODS: Retrospective analysis of patients with EFE who underwent diagnostic transconjunctival 23-G vitrectomy at a tertiary referral center.RESULTS: Nineteen eyes of 15 patients with EFE were included in the study. Four patients had bilateral and 11 patients unilateral disease. Sixteen eyes of 15 patients underwent 23-G vitrectomy to confirm the diagnosis using vitreous culture, polymerase chain reaction, and histopathologic examinations. All affected eyes were treated with intravitreal amphotericin B 5 µg/0.1 mL. Fourteen patients received additional systemic antifungal therapy. Diagnostic 23-G vitrectomy confirmed the diagnosis of EFE in 75% of the eyes (12/16). Candida was found to be a causative agent in 62.5% and Aspergillus in 12.5% of the eyes. Retinal detachment was the most common complication (42% of eyes).CONCLUSIONS: EFE can be easily confirmed using primary 23-G vitrectomy.

U2 - 10.3109/09273948.2015.1115080

DO - 10.3109/09273948.2015.1115080

M3 - SCORING: Journal article

C2 - 26829468

VL - 25

SP - 239

EP - 245

JO - OCUL IMMUNOL INFLAMM

JF - OCUL IMMUNOL INFLAMM

SN - 0927-3948

IS - 2

ER -